COVID up first as social data science gets a new center with an assist from Facebook

The emerging academic discipline of social data science, which leverages Big Data to integrate social science with computer science, has a new base of operations in the Mid-Atlantic region.  

Called SoDa for short, the University of Maryland’s Social Science Data Center partners its colleges of information studies (iSchool) and behavioral and social sciences (BSOS).

Meanwhile the center will tap Facebook to help with research and education programs over the next three years.

In fact, SoDa is already working with the social media giant and other universities, rallying participating entities around a survey project to address the COVID crisis, according to an announcement from the school.

For that work, Facebook is helping gather global data on people who believe they may have the virus based on symptoms. The aim is to predict infection hotspots in the U.S. and around the world.

Going forward, SoDa leadership hopes to spearhead the introduction of a Social Data Science undergraduate major at U of Maryland, according to the announcement.

SoDa’s executive director, Jody Williams, says demand has been growing for social data scientists who have the knowledge and skills needed to analyze massive datasets and connect Big Data to human behavior.

“The value is in the treatment of that data,” Williams adds. “The mission of SoDa focuses on the mindful use of social scientific methodology and analytics in research, education and application of complex digital data, key components to extracting valuable insights from modern everyday life.”

More details are posted at the center’s dedicated website.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.